Concepedia

Véronique Cruciani

VC

Statistics

Publications

21

Citations

759

H-Index

16

Active since

1997

Affiliations

Norwegian Cancer Society(Current)

Bayer (Germany)

Bayer (Norway)

Oslo University Hospital

Norwegian Institute of Public Health

Véronique Cruciani is an author at Norwegian Cancer Society specializing in medicine, cell biology, and cell communication.

Top concepts

Publications per year

1997–2024

21

Publications

21

Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers

Urs B. Hagemann, Christine Ellingsen, Joachim Schuhmacher et al. · Clinical Cancer Research · 2019 · 106 citations

Ischemia Induces Closure of Gap Junctional Channels and Opening of Hemichannels in Heart-derived Cells and Tissue

David Johansen, Véronique Cruciani, Rune Sundset et al. · Cellular Physiology and Biochemistry · 2011 · 62 citations · Full text

Evolutionary selection pressure and family relationships among connexin genes

Véronique Cruciani, Svein‐Ole Mikalsen · Biological Chemistry · 2007 · 61 citations

Synergistic Effect of a Mesothelin-Targeted <sup>227</sup>Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models

Katrine Wickstroem, Urs B. Hagemann, Véronique Cruciani et al. · Journal of Nuclear Medicine · 2019 · 51 citations · Full text

, , +17

Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy

Pascale Lejeune, Véronique Cruciani, Axel Berg‐Larsen et al. · Journal for ImmunoTherapy of Cancer · 2021 · 50 citations · Full text

1–5 of 21